Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitors

References

• Hurley LH. DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer 2002; 2:188 - 200; http://dx.doi.org/10.1038/nrc749; PMID: 11990855
   PubMed Web of Science ®Google Scholar
• Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 2004; 4:737 - 47; http://dx.doi.org/10.1038/nrc1451; PMID: 15343280
   PubMed Web of Science ®Google Scholar
• Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, et al. Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 2004; 104:14 - 20; http://dx.doi.org/10.1159/000077461; PMID: 15162010
   PubMed Web of Science ®Google Scholar
• Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst) 2007; 6:923 - 35; http://dx.doi.org/10.1016/j.dnarep.2007.02.006; PMID: 17363343
   PubMed Web of Science ®Google Scholar
• Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. Cell Res 2008; 18:134 - 47; http://dx.doi.org/10.1038/cr.2007.111; PMID: 18157161
   PubMed Web of Science ®Google Scholar
• Dikomey E, Dahm-Daphi J, Brammer I, Martensen R, Kaina B. Correlation between cellular radiosensitivity and non-repaired double-strand breaks studied in nine mammalian cell lines. Int J Radiat Biol 1998; 73:269 - 78; http://dx.doi.org/10.1080/095530098142365; PMID: 9525255
   PubMed Web of Science ®Google Scholar
• Tan DS-W, Gerlinger M, Teh B-T, Swanton C. Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference. Eur J Cancer 2010; 46:2166 - 77; http://dx.doi.org/10.1016/j.ejca.2010.03.019; PMID: 20413300
   PubMed Web of Science ®Google Scholar
• Madhusudan S, Hickson ID. DNA repair inhibition: a selective tumour targeting strategy. Trends Mol Med 2005; 11:503 - 11; http://dx.doi.org/10.1016/j.molmed.2005.09.004; PMID: 16214418
   PubMed Web of Science ®Google Scholar
• Ding J, Miao ZH, Meng LH, Geng MY. Emerging cancer therapeutic opportunities target DNA-repair systems. Trends Pharmacol Sci 2006; 27:338 - 44; http://dx.doi.org/10.1016/j.tips.2006.04.007; PMID: 16697054
   PubMed Web of Science ®Google Scholar
• Curtin N. Therapeutic potential of drugs to modulate DNA repair in cancer. Expert Opin Ther Targets 2007; 11:783 - 99; http://dx.doi.org/10.1517/14728222.11.6.783; PMID: 17504016
   PubMed Web of Science ®Google Scholar
• Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 2008; 8:193 - 204; http://dx.doi.org/10.1038/nrc2342; PMID: 18256616
   PubMed Web of Science ®Google Scholar
• Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res 2008; 36:5678 - 94; http://dx.doi.org/10.1093/nar/gkn550; PMID: 18772227
   PubMed Web of Science ®Google Scholar
• An J, Huang Y-C, Xu Q-Z, Zhou L-J, Shang Z-F, Huang B, et al. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression. BMC Mol Biol 2010; 11:18; http://dx.doi.org/10.1186/1471-2199-11-18; PMID: 20205745
   PubMed Web of Science ®Google Scholar
• Kohn KW, Grimek-Ewig RA. Alkaline elution analysis, a new approach to the study of DNA single-strand interruptions in cells. Cancer Res 1973; 33:1849 - 53; PMID: 4737199
   PubMed Web of Science ®Google Scholar
• Olive PL, Banáth JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 2006; 1:23 - 9; http://dx.doi.org/10.1038/nprot.2006.5; PMID: 17406208
   PubMed Web of Science ®Google Scholar
• Van Kooij RJ, de Boer P, De Vreeden-Elbertse JM, Ganga NA, Singh N, Te Velde ER. The neutral comet assay detects double strand DNA damage in selected and unselected human spermatozoa of normospermic donors. Int J Androl 2004; 27:140 - 6; http://dx.doi.org/10.1111/j.1365-2605.2004.00463.x; PMID: 15139968
   PubMed Web of Science ®Google Scholar
• Ostling O, Johanson KJ. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 1984; 123:291 - 8; http://dx.doi.org/10.1016/0006-291X(84)90411-X; PMID: 6477583
   PubMed Web of Science ®Google Scholar
• Fairbairn DW, Olive PL, O’Neill KL. The comet assay: a comprehensive review. Mutat Res 1995; 339:37 - 59; http://dx.doi.org/10.1016/0165-1110(94)00013-3; PMID: 7877644
   PubMed Web of Science ®Google Scholar
• Collins AR, Oscoz AA, Brunborg G, Gaivão I, Giovannelli L, Kruszewski M, et al. The comet assay: topical issues. Mutagenesis 2008; 23:143 - 51; http://dx.doi.org/10.1093/mutage/gem051; PMID: 18283046
   PubMed Web of Science ®Google Scholar
• Belyaev IY, Eriksson S, Nygren J, Torudd J, Harms-Ringdahl M. Effects of ethidium bromide on DNA loop organisation in human lymphocytes measured by anomalous viscosity time dependence and single cell gel electrophoresis. Biochim Biophys Acta 1999; 1428:348 - 56; http://dx.doi.org/10.1016/S0304-4165(99)00076-8; PMID: 10434054
   PubMed Web of Science ®Google Scholar
• García O, Mandina T, Lamadrid AI, Diaz A, Remigio A, Gonzalez Y, et al. Sensitivity and variability of visual scoring in the comet assay. Results of an inter-laboratory scoring exercise with the use of silver staining. Mutat Res 2004; 556:25 - 34; PMID: 15491629
   PubMed Web of Science ®Google Scholar
• Forchhammer L, Johansson C, Loft S, Möller L, Godschalk RWL, Langie SAS, et al. Variation in the measurement of DNA damage by comet assay measured by the ECVAG inter-laboratory validation trial. Mutagenesis 2010; 25:113 - 23; http://dx.doi.org/10.1093/mutage/gep048; PMID: 19910383
   PubMed Web of Science ®Google Scholar
• Wood DK, Weingeist DM, Bhatia SN, Engelward BP. Single cell trapping and DNA damage analysis using microwell arrays. Proc Natl Acad Sci USA 2010; 107:10008 - 13; http://dx.doi.org/10.1073/pnas.1004056107; PMID: 20534572
   PubMed Web of Science ®Google Scholar
• Wojewódzka M, Buraczewska I, Kruszewski M. A modified neutral comet assay: elimination of lysis at high temperature and validation of the assay with anti-single-stranded DNA antibody. Mutat Res 2002; 518:9 - 20; http://dx.doi.org/10.1016/S1383-5718(02)00070-0; PMID: 12063063
   PubMed Web of Science ®Google Scholar
• Nichols C, Kollmannsberger C. First-line chemotherapy of disseminated germ cell tumors. Hematol Oncol Clin North Am 2011; 25:543 - 56, viii; http://dx.doi.org/10.1016/j.hoc.2011.03.011; PMID: 21570608
   PubMed Web of Science ®Google Scholar
• Richardson SE, McNamara C. The Management of Classical Hodgkin’s Lymphoma: Past, Present, and Future. Adv Hematol 2011; 2011:865870; http://dx.doi.org/10.1155/2011/865870; PMID: 21687653
   PubMedGoogle Scholar
• Linnert M, Gehl J. Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs 2009; 20:157 - 64; http://dx.doi.org/10.1097/CAD.0b013e328325465e; PMID: 19396014
   PubMed Web of Science ®Google Scholar
• Feldmann E, Schmiemann V, Goedecke W, Reichenberger S, Pfeiffer P. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res 2000; 28:2585 - 96; http://dx.doi.org/10.1093/nar/28.13.2585; PMID: 10871410
   PubMed Web of Science ®Google Scholar
• Hammel M, Yu Y, Mahaney BL, Cai B, Ye R, Phipps BM, et al. Ku and DNA-dependent protein kinase dynamic conformations and assembly regulate DNA binding and the initial non-homologous end joining complex. J Biol Chem 2010; 285:1414 - 23; http://dx.doi.org/10.1074/jbc.M109.065615; PMID: 19893054
   PubMed Web of Science ®Google Scholar
• Ismail IH, Mårtensson S, Moshinsky D, Rice A, Tang C, Howlett A, et al. SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization. Oncogene 2004; 23:873 - 82; http://dx.doi.org/10.1038/sj.onc.1207303; PMID: 14661061
   PubMed Web of Science ®Google Scholar
• Losada R, Rivero MT, Slijepcevic P, Goyanes V, Fernández JL. Effect of Wortmannin on the repair profiles of DNA double-strand breaks in the whole genome and in interstitial telomeric sequences of Chinese hamster cells. Mutat Res 2005; 570:119 - 28; http://dx.doi.org/10.1016/j.mrfmmm.2004.10.009; PMID: 15680409
   PubMed Web of Science ®Google Scholar
• Perrault R, Wang H, Wang M, Rosidi B, Iliakis G. Backup pathways of NHEJ are suppressed by DNA-PK. J Cell Biochem 2004; 92:781 - 94; http://dx.doi.org/10.1002/jcb.20104; PMID: 15211575
   PubMed Web of Science ®Google Scholar
• Takahashi A, Ohnishi T. Does gammaH2AX foci formation depend on the presence of DNA double strand breaks?. Cancer Lett 2005; 229:171 - 9; http://dx.doi.org/10.1016/j.canlet.2005.07.016; PMID: 16129552
   PubMed Web of Science ®Google Scholar
• Collis SJ, DeWeese TL, Jeggo PA, Parker AR. The life and death of DNA-PK. Oncogene 2005; 24:949 - 61; http://dx.doi.org/10.1038/sj.onc.1208332; PMID: 15592499
   PubMed Web of Science ®Google Scholar
• Hosoi Y, Miyachi H, Matsumoto Y, Ikehata H, Komura J, Ishii K, et al. A phosphatidylinositol 3-kinase inhibitor wortmannin induces radioresistant DNA synthesis and sensitizes cells to bleomycin and ionizing radiation. Int J Cancer 1998; 78:642 - 7; http://dx.doi.org/10.1002/(SICI)1097-0215(19981123)78:5<642::AID-IJC19>3.0.CO;2-3; PMID: 9808536
   PubMed Web of Science ®Google Scholar
• Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269:5241 - 8; PMID: 8106507
   PubMed Web of Science ®Google Scholar
• Hollick JJ, Golding BT, Hardcastle IR, Martin N, Richardson C, Rigoreau LJM, et al. 2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK). Bioorg Med Chem Lett 2003; 13:3083 - 6; http://dx.doi.org/10.1016/S0960-894X(03)00652-8; PMID: 12941339
   PubMed Web of Science ®Google Scholar
• Leahy JJ, Golding BT, Griffin RJ, Hardcastle IR, Richardson C, Rigoreau L, et al. Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg Med Chem Lett 2004; 14:6083 - 7; http://dx.doi.org/10.1016/j.bmcl.2004.09.060; PMID: 15546735
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Fontana G, Golding BT, Guiard S, Hardcastle IR, Leahy JJ, et al. Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro. J Med Chem 2005; 48:569 - 85; http://dx.doi.org/10.1021/jm049526a; PMID: 15658870
   PubMed Web of Science ®Google Scholar
• Kashishian A, Douangpanya H, Clark D, Schlachter ST, Eary CT, Schiro JG, et al. DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer. Mol Cancer Ther 2003; 2:1257 - 64; PMID: 14707266
   PubMed Web of Science ®Google Scholar
• Zhao Y, Thomas HD, Batey MA, Cowell IG, Richardson CJ, Griffin RJ, et al. Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res 2006; 66:5354 - 62; http://dx.doi.org/10.1158/0008-5472.CAN-05-4275; PMID: 16707462
   PubMed Web of Science ®Google Scholar
• Chen H, Ma Z, Vanderwaal RP, Feng Z, Gonzalez-Suarez I, Wang S, et al. The mTOR inhibitor rapamycin suppresses DNA double-strand break repair. Radiat Res 2011; 175:214 - 24; http://dx.doi.org/10.1667/RR2323.1; PMID: 21268715
   PubMed Web of Science ®Google Scholar
• Kiskinis E, Suter W, Hartmann A. High throughput Comet assay using 96-well plates. Mutagenesis 2002; 17:37 - 43; http://dx.doi.org/10.1093/mutage/17.1.37; PMID: 11752232
   PubMed Web of Science ®Google Scholar
• Priestley A, Beamish HJ, Gell D, Amatucci AG, Muhlmann-Diaz MC, Singleton BK, et al. Molecular and biochemical characterisation of DNA-dependent protein kinase-defective rodent mutant irs-20. Nucleic Acids Res 1998; 26:1965 - 73; http://dx.doi.org/10.1093/nar/26.8.1965; PMID: 9518490
   PubMed Web of Science ®Google Scholar
• Izzard RA, Jackson SP, Smith GC. Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer Res 1999; 59:2581 - 6; PMID: 10363977
   PubMed Web of Science ®Google Scholar
• Kumar A, Fernandez-Capetillo O, Carrera AC, Carrera AC. Nuclear phosphoinositide 3-kinase beta controls double-strand break DNA repair. Proc Natl Acad Sci USA 2010; 107:7491 - 6; http://dx.doi.org/10.1073/pnas.0914242107; PMID: 20368419
   PubMed Web of Science ®Google Scholar
• Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008; 27:5497 - 510; http://dx.doi.org/10.1038/onc.2008.245; PMID: 18794884
   PubMed Web of Science ®Google Scholar
• Mazzoletti M, Bortolin F, Brunelli L, Pastorelli R, Di Giandomenico S, Erba E, et al. Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates. Cancer Res 2011; 71:4573 - 84; http://dx.doi.org/10.1158/0008-5472.CAN-10-4322; PMID: 21602434
   PubMed Web of Science ®Google Scholar
• Dokmanovic M, Clarke C, Marks PA. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 2007; 5:981 - 9; http://dx.doi.org/10.1158/1541-7786.MCR-07-0324; PMID: 17951399
   PubMed Web of Science ®Google Scholar